Corporate News 27-Jan-23
Gland Pharma's Visakhapatnam facility concludes USFDA inspection
Gland Pharma announced that the United States Food and Drug Administration (US FDA) conducted an inspection at the Company's API Facility at JNPC, Visakhapatnam from 23 January 2023 to 27 January 2023 and has been completed with Zero observations.
Previous News
Gland Pharma
( Results - Analysis 23-May-24 10:29 )
Gland Pharma
( Results - Analysis 07-Aug-24 09:34 )
Gland Pharma
( Results - Analysis 15-Feb-24 11:08 )
Gland Pharma Ltd gains for third straight session
( Hot Pursuit - 20-Dec-23 13:05 )
Gland Pharma's Dundigal unit receives Establishment Inspection Report from USFDA
( Corporate News - 24-Aug-23 11:59 )
US FDA issues 3 Form 483 observations to Gland Pharma's Pashamylaram facility
( Hot Pursuit - 05-Aug-24 12:19 )
Gland Pharma consolidated net profit rises 33.77% in the December 2021 quarter
( Results - Announcements 21-Jan-22 16:41 )
Gland Pharma
( Results - Analysis 21-Jan-22 18:45 )
Volumes spurt at Krishna Institute of Medical Sciences Ltd counter
( Hot Pursuit - 08-Aug-23 14:30 )
Gland Pharma consolidated net profit rises 38.02% in the September 2021 quarter
( Results - Announcements 22-Oct-21 16:56 )
Board of Gland Pharma approves change in directorate
( Corporate News - 10-Mar-22 17:20 )
Other Stories
ITD Cementation India wins order of Rs 1,937 cr
03-Oct-24 10:35
NIIT Learning Systems allots 1,666 equity shares under ESOP
03-Oct-24 10:30
Ashoka Metcast to discuss results
03-Oct-24 10:29
Emerald Finance to declare Quarterly Result
03-Oct-24 10:29
Rhetan TMT schedules board meeting
03-Oct-24 10:29
Shrenik to table results
03-Oct-24 10:29
Universal Arts to declare Quarterly Result
03-Oct-24 10:28
Three M Paper Boards to conduct board meeting
03-Oct-24 10:28
Arkade Developers to declare Quarterly Result
03-Oct-24 10:28
Worth Investment & Trading Company announces board meeting date
03-Oct-24 10:28
Back
Top
